leucovorin,gemcitabine,nab-paclitaxel,oxaliplatin,5-fluorouracil
ipsen
['napoli 3', 'pancsm']
according to the phase 3 napoli 3 study presented at #asco2023, statistically significant and clinically meaningful improvements in os &amp; pfs were achieved with #nalirifox in patients with treatment-na ve metastatic #pdac. #pancsm | 
Oncology news and insights from leading researchers and cancer centers.